Light-Up Sensor Detects Banned Antibiotic in Water
A single unmodified DNA strand reliably signals chloramphenicol at low concentrations without labels or specialized reagents.
Updated on Nov. 10, 2026 in Biotech

Researchers reported S-CAP, a label-free light-up aptamer sensor built from one unmodified DNA strand, for detecting chloramphenicol. The sensor responds linearly from 16.2 to 646 µg/L and was tested in aquaculture water samples.
Why it matters
Chloramphenicol is banned in food-producing animals, yet illicit use persists in aquaculture, and confirmatory LC-MS/MS testing is too costly for routine screening. A simple, low-cost detection method could make routine monitoring more practical for regulators and producers.
The sensor's apparent dissociation constant of 1.27 ± 0.13 µM is markedly tighter than the 9.8 µM reported for the parent CAP1 aptamer, with a detection limit of 4.4 µg/L. Recoveries ranged from 91.2 to 107.4% and agreed within ±8% of LC-MS/MS results, though the extraction does not describe performance outside the tested matrices.
The details
The S-CAP design uses no label, quencher, nanomaterial, or enzyme, and the transducer stem was chosen by systematically varying stem length and G/C content. A mutant retaining about one third of the response suggests the signal depends on the transducer itself.
Timeline
Binding measurements were taken after 30 minutes at 25 °C.
Biotech Context
The sensor offers a route around the cost barrier of LC-MS/MS, which the extraction identifies as too expensive for routine chloramphenicol screening. Its label-free, single-strand design positions it as a simpler aptamer-based alternative to confirmatory instrumentation.
For food producers and regulators, a low-cost, label-free test could make routine chloramphenicol screening more feasible than current confirmatory methods. The extraction does not indicate when or whether the sensor will be available for commercial use.
The takeaway
Simpler sensor designs may expand routine monitoring of banned veterinary antibiotics in aquaculture, where cost has limited testing. Practical adoption will depend on validation beyond the laboratory conditions reported so far.
Further reading
Explore more Biotech developments on the site.
Source note: This article includes information reported by Nature.







